Article
Therapies based on targeting Epstein‐Barr virus lytic replication for EBV ‐associated malignancies
11 May 2018
Abstract excerpt
In recent years, Epstein-Barr virus (EBV) lytic infection has been shown to significantly contribute to carcinogenesis. Thus, therapies aimed at targeting the EBV lytic cycle have been developed as novel strategies for treatment of EBV-associated malignancies. In this review, focusing on the viral lytic proteins, we describe recent advances regarding the involvement of the EBV lytic cycle in carcinogenesis....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
